Prostaglandin-induced cortical hyperostosis in infants with cyanotic congenital heart disease
Author:
Bell Daniel,Ashraf Ammar
Publisher
Radiopaedia.org
Reference6 articles.
1. Ashraf A, Saeed U, Alhadi O, Asad-ur-Rehman and Iqbal S: Prolonged prostaglandin in-fusion and cortical hyperostosis in an infant with cyanotic congenital heart disease. Int J Pharm Sci & Res 2018; 9(1): 369-72. doi: 10.13040/IJPSR.0975-8232.9(1).369-72.
2. Velaphi S, Cilliers A, Beckh-Arnold E, Mokhachane M, Mphahlele R, Pettifor J. Cortical Hyperostosis in an Infant on Prolonged Prostaglandin Infusion: Case Report and Lit-erature Review. (2004) Journal of Perinatology. 24 (4): 263.
3. Estes K, Nowicki M, Bishop P. Cortical hyperostosis secondary to prostaglandin E1 ther-apy. (2007) The Journal of pediatrics. 151 (4): 441, 441.e1.
4. Akkinapally S, Hundalani SG, Kulkarni M, et al. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions. The Cochrane Database of Systematic Reviews. 2018 Feb;2:CD011417. DOI: 10.1002/14651858.cd011417.pub2.
5. ALMEIDA, João Fernando Lourenço de et al. Cortical Hyperostosis Secondary to Pro-longed Use of Prostaglandin E1. (2007) Clinics (Sao Paulo, Brazil).